Evidence map›Paper›PMID 38224191›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2024

Trends in blood pressure changes and hypertension prevalence in Australian adults before and during the COVID-19 pandemic.

Janis M Nolde, Fleur Streets, Denny Meyer, Won Sun Chen, Jiajun Wei, Nilmini Wickramasinghe, Patrick Hannebery, Gavin W Lambert, Markus P Schlaich

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Janis M NoldeDobney Hypertension Centre, Medical School - Royal Perth Hospital Unit / Medical Research Foundation, University of Western Australia, Perth, Australia.ORCID 0000-0001-6864-8514
Fleur StreetsSISU Health Group, Melbourne, Australia.
Denny MeyerDepartment of Health Science and Biostatistics, School of Health Sciences, Swinburne University of Technology, Melbourne, Australia.
Won Sun ChenDepartment of Health Science and Biostatistics, School of Health Sciences, Swinburne University of Technology, Melbourne, Australia.
Jiajun WeiSISU Health Group, Melbourne, Australia.
Nilmini WickramasingheIverson Health Innovation Research Institute and School of Health Sciences, Swinburne University of Technology, Melbourne, Australia.
Patrick HanneberySISU Health Group, Melbourne, Australia.
Gavin W LambertIverson Health Innovation Research Institute and School of Health Sciences, Swinburne University of Technology, Melbourne, Australia.ORCID 0000-0003-0315-645X
Markus P SchlaichDobney Hypertension Centre, Medical School - Royal Perth Hospital Unit / Medical Research Foundation, University of Western Australia, Perth, Australia.ORCID 0000-0002-1765-0195
Swinburne University of Technology · AUMelbourne Health · AUBaker Heart and Diabetes Institute · AUThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efforts to limit the impact of the coronavirus disease (COVID-19) pandemic led to the implementation of public health measures and reallocation of health resources. To investigate trends in blood pressure (BP), hypertension and BMI in the Australian population during the COVID-19 pandemic, data from publicly accessible health stations were analyzed. Average BP and BMI measured by the SiSU Health Station network in Australia in over 1.6 million health screenings were compared between the years 2018 and 2021. Additionally, paired trajectories for BP and BMI development before and during the COVID-19 pandemic were calculated. Comparisons between pre-COVID years and post-COVID years of 2018 versus 2020, 2019 versus 2020, 2018 versus 2021, and 2019 versus 2021 showed increases in average adjusted systolic BP of 2.0, 1.7, 2.6, and 2.3 mmHg, respectively. Paired analysis of longitudinal data showed an overall increase in the trajectory of systolic BP of 3.2 mmHg between pre- and post-COVID years. The prevalence of hypertension in users of the health stations increased by approximately 25% in the years 2020-2021. Similar trends were seen for BMI. Data from public Australian health stations indicated a strong trend toward higher BP during the COVID-19 pandemic. At the population level, BP increments have been shown to markedly increase cardiovascular disease risk. Anti-pandemic measures need to be carefully evaluated in terms of secondary public health effects and health support systems extended to effectively target cardiovascular risk.

Indexed as

COVID-19HypertensionAdultAustraliaBlood PressureHumansPandemicsPrevalencecardiovascular riskCOVID-19hypertensionobesitypandemicpublic health

Identifiers

PMID38224191
PMCPMC10857471
OpenAlexW4390879640

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.